Integer (ITGR) Competitors $105.44 -0.78 (-0.74%) Closing price 09/9/2025 03:59 PM EasternExtended Trading$105.48 +0.04 (+0.04%) As of 09/9/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ITGR vs. BDSX, ELV, HOLX, BAX, GMED, MASI, TFX, ATEC, ATRC, and IARTShould you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "medical" sector. Integer vs. Its Competitors Biodesix Elevance Health Hologic Baxter International Globus Medical Masimo Teleflex Alphatec AtriCure Integra LifeSciences Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability. Do insiders & institutionals believe in BDSX or ITGR? 21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 30.1% of Biodesix shares are owned by company insiders. Comparatively, 2.2% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is BDSX or ITGR more profitable? Integer has a net margin of 4.61% compared to Biodesix's net margin of -53.66%. Integer's return on equity of 12.27% beat Biodesix's return on equity.Company Net Margins Return on Equity Return on Assets Biodesix-53.66% -269.67% -43.94% Integer 4.61%12.27%6.23% Which has higher valuation & earnings, BDSX or ITGR? Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodesix$71.32M0.95-$42.93M-$0.29-1.60Integer$1.72B2.15$119.90M$2.2746.45 Does the media prefer BDSX or ITGR? In the previous week, Integer had 3 more articles in the media than Biodesix. MarketBeat recorded 8 mentions for Integer and 5 mentions for Biodesix. Biodesix's average media sentiment score of 1.47 beat Integer's score of 1.06 indicating that Biodesix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate BDSX or ITGR? Biodesix currently has a consensus price target of $1.75, indicating a potential upside of 276.99%. Integer has a consensus price target of $140.25, indicating a potential upside of 33.02%. Given Biodesix's higher probable upside, equities analysts clearly believe Biodesix is more favorable than Integer.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodesix 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Integer 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility & risk, BDSX or ITGR? Biodesix has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Integer has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. SummaryInteger beats Biodesix on 14 of the 17 factors compared between the two stocks. Get Integer News Delivered to You Automatically Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ITGR vs. The Competition Export to ExcelMetricIntegerMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$3.72B$7.02B$5.83B$21.32BDividend YieldN/A1.20%5.28%3.49%P/E Ratio46.4526.4875.6929.42Price / Sales2.15135.90544.7868.57Price / Cash11.9322.1637.2024.61Price / Book2.185.0411.504.55Net Income$119.90M$176.38M$3.28B$999.91M7 Day Performance-0.28%1.49%1.42%0.93%1 Month Performance-0.91%4.82%11.28%5.24%1 Year Performance-14.35%9.41%59.03%16.56% Integer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ITGRInteger4.142 of 5 stars$105.44-0.7%$140.25+33.0%-15.3%$3.72B$1.72B46.4511,000Positive NewsBDSXBiodesix3.4355 of 5 stars$0.43-4.4%$1.75+310.2%-74.1%$62.55M$71.32M-1.47220Positive NewsHigh Trading VolumeELVElevance Health4.7954 of 5 stars$319.00+2.8%$413.81+29.7%-42.0%$71.75B$177.01B13.57104,200HOLXHologic4.8677 of 5 stars$67.12+0.8%$78.00+16.2%-19.3%$14.93B$4.03B27.857,063Positive NewsAnalyst UpgradeBAXBaxter International4.8561 of 5 stars$24.72+1.3%$30.11+21.8%-37.6%$12.68B$10.64B-82.3838,000Positive NewsGMEDGlobus Medical4.8727 of 5 stars$61.26+0.2%$87.64+43.1%-15.6%$8.27B$2.52B23.565,300Positive NewsMASIMasimo4.699 of 5 stars$139.71-0.9%$193.60+38.6%+33.0%$7.59B$2.09B-16.405,600Positive NewsTFXTeleflex4.6182 of 5 stars$126.58+0.3%$141.57+11.8%-46.8%$5.59B$3.05B29.7814,100Positive NewsAnalyst UpgradeATECAlphatec4.2325 of 5 stars$15.90-0.8%$18.50+16.4%+179.6%$2.35B$611.56M-14.07700Analyst UpgradeATRCAtriCure3.5021 of 5 stars$36.99-0.6%$50.89+37.6%+37.6%$1.84B$465.31M-48.041,300News CoveragePositive NewsIARTIntegra LifeSciences3.7227 of 5 stars$15.13+2.0%$18.43+21.8%-12.2%$1.18B$1.61B-2.324,396Positive News Related Companies and Tools Related Companies BDSX Alternatives ELV Alternatives HOLX Alternatives BAX Alternatives GMED Alternatives MASI Alternatives TFX Alternatives ATEC Alternatives ATRC Alternatives IART Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ITGR) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredUnlock Friday's Full Potential: Two Simple Sentences that put profits in investors’ pocketsMost traders stick to the same routine each week. But a little-known market strategy has quietly delivered a 9...Eagle Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integer Holdings Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Integer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.